Our RESETTM clinical trials with rese-cel (investigational CD19-CAR T cell therapy) in lupus, myositis, systemic sclerosis, and pemphigus vulgaris are now recruiting.
Recent News View All News
Email Alerts
Sign up for email alerts for Press Releases & SEC Filings